NAS:CNCR

Range Cancer Therapeutics ETF

$ 15.16 0.2 ( +1.34%) 03:36 PM EST
PE Ratio:
32.48
PB Ratio:
1.86
Volume:
3.52K
Dividend Yield %:
0
Last Holding update 2024-10-25 75 Stocks (0 new)
Value $13.00 Mil Turnover 0 %
Portfolio Report
Registrant: Range Cancer Therapeutics ETF
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
This section is for PremiumPlus GuruFocus PremiumPlus Icon Membership subscribers only.
GuruFocus PremiumPlus GuruFocus PremiumPlus Icon Membership
  Backtesting
  13F, 13D/G of all institutional investors
  Aggregated portfolio of any combinations among them
  FilingWiz
  Excel Add-In unlimited queries
  API (20,000 queries/month)

Discussions on Range Cancer Therapeutics ETF

User's Avatar
How would you rate this stock? CNCR
No discussions yet.